Nabumetone Tablet
Product Images NDC 71335-1391

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 71335-1391). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

This is a graph depicting Nabumetone Active Metabolite (BMNA) plasma concentrations at steady state following once-daily dosing of Nabumetone 1000 mg (n=31) and 2000 mg (n=12) over a period of time (in hours).*

FDA Label Image

Label Image (Lbl713351391)

This text appears to be a identification and comparison of a medication called "Relafen 500mg Tablet" manufactured by ScieGen Pharmaceuticals Inc. The packaging appears to have been done by Bryant Ranck Prepack, and the medication is contained in a package of 20 tablets with an expiry date of MM/YY. The NDC number is 7133513911. The prescription labels should be examined prior to use. The text instructs to keep the medication at room temperature, specifically 20°-25°C (68°-77°F). The medication should also be kept out of children's reach.*

FDA Label Image

Structure1 (Structure1)

FDA Label Image

Structure2 (Structure2)

6-methoxy-2-naphthylacetic acid (SMNA) is a chemical compound with the molecular formula COOH CHgO.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.